Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents	$ 99,922	$ 2,623
Accounts receivable, net	368,611	244,251
Fair value of derivatives	7,559	48,869
Prepaid expenses and other current assets	8,602	12,505
Total current assets	484,694	308,248
Properties and equipment, net	4,826,337	4,859,199
Fair value of derivatives	12,742	9,565
Other assets	43,492	60,961
Total Assets	5,367,265	5,237,973
Current liabilities:
Accounts payable	143,931	90,635
Production tax liability	86,914	124,475
Fair value of derivatives	454,578	98,152
Funds held for distribution	261,547	177,132
Accrued interest payable	20,948	14,734
Other accrued expenses	85,520	81,715
Current portion of long-term debt	0	193,014
Total current liabilities	1,053,438	779,857
Long-term debt	1,243,235	1,409,548
Asset retirement obligations	118,361	132,637
Fair value of derivatives	133,631	36,359
Other liabilities	274,376	264,034
Total liabilities	2,823,041	2,622,435
Stockholders' Equity:
Common shares - par value $0.01 per share, 150,000,000 authorized, 97,440,523 and 99,758,720 issued as of September 30, 2021 and December 31, 2020, respectively	974	998
Additional paid-in capital	3,267,261	3,387,754
Accumulated deficit	(723,017)	(772,265)
Treasury shares - at cost, 20,958 and 37,510 as of September 30, 2021 and December 31, 2020, respectively	(994)	(949)
Total stockholders’ equity	2,544,224	2,615,538
Total Liabilities and Stockholders’ Equity	$ 5,367,265	$ 5,237,973
Common stock, shares authorized	150,000,000